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End of Life Considerations in the Extracorporeal Membrane
Oxygenation (ECMO) Patient - A Case Presentation
Jonathan Abraham MD, Jonathan Rose MD, Division of Hospice &
Palliative Medicine - Henry Ford Health System, Detroit, Michigan
Learning Objectives
1. Understand ECMO basics - its utility, indications, and
importance to the palliative care provider
2. Describe unique clinical challenges associated with
terminal weans of ECMO in an awake patient
3. Identify potential areas for future research regarding
terminal weaning of ECMO

How ECMO Works
In basic terms, ECMO can be thought of as a heart-lung
bypass machine, taking over the role of oxygenation,
ventilation and/or generating cardiac output when the lungs
(VV) and/or heart (VA) are failing.

Introduction: What is ECMO?

Extracorporeal membrane oxygenation (ECMO) is
an emerging life-sustaining intervention for
patients experiencing critical cardiopulmonary
compromise. ECMO is a “bridge” therapy,
reserved for the most critically ill patients. Despite
the promises of this intervention, studies have
shown that over 40% of patients receiving ECMO
do not survive their hospitalization.1 In light of
this, existing research and protocols for weaning
ECMO in the setting of medical futility is
extremely limited.2,4 Additionally, research
suggests that medications may work differently for
patients receiving ECMO3, raising questions about
the development of future protocols in this patient
population.

Figure 1. A patient being cannulated for VA ECMO

Figure 2. ECMO circuit diagram,

A Clinical Case
60 year-old female with a history of pulmonary
sarcoidosis who was hospitalized for acute-on-chronic
hypoxic respiratory failure, complicated by inhospital cardiac arrest. She was ultimately
resuscitated and placed on VA-ECMO as a bridge to
lung transplantation. After several weeks during her
hospitalization, she remained awake and conversant.
She developed multiple complications and was
subsequently informed that she was no longer a
candidate for transplantation or ECMO support. The
patient and her family were able to participate in a
goals of care discussion and the decision was made to
discontinue ECMO. Prior to the ECMO wean, she
received boluses of IV morphine and lorazepam, and
a morphine infusion was initiated. Her ECMO was
weaned to 50% settings, and then discontinued
altogether as medications were titrated. Despite this,
the patient was noted to have evidence of respiratory
distress including accessory muscle use. She died
approximately 20 minutes after discontinuation of
ECMO.

Take Home Points

• ECMO is an emerging life-sustaining
therapy for some of the most critically ill
patients
• ECMO utilization in the U.S. has grown
exponentially over the past decade5
• ECMO patients and their families often
have a large palliative care need
• There is minimal research on symptom
management or established protocols for
patients undergoing a terminal ECMO
wean
• Interpolating wean protocols from other
life-sustaining interventions (e.g.
mechanical ventilation) may not yield
anticipated or satisfactory results
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